LUCIRA HEALTH INC
Share · US54948U1051 · LHDX (XNAS)
No Price
n/a
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 0,00 % | -98,19 % |
Company Profile for LUCIRA HEALTH INC Share
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California.
Company Data
Name LUCIRA HEALTH INC
Company Lucira Health, Inc.
Symbol LHDX
Website https://www.lucirahealth.com
Primary Exchange
NASDAQ
ISIN US54948U1051
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Mr. Erik T. Engelson
Market Capitalization 18 Mio
Country United States of America
Currency USD
Employees 0,2 T
Address 1412 62nd Street, 94608 EmeryVille
IPO Date 2021-02-04
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | LHDX |
More Shares
Investors who LUCIRA HEALTH INC hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.